Diabetes There is emerging evidence that cannabidiol may help slow cell damage in diabetes mellitus type 1 92 There is a lack of meaningful evidence of the effects of medical cannabis use on people with diabetes; a 2010 review concluded that “the potential risks and Rick Simpson Oil Weedmaps Los Angeles benefits for diabetic patients
remain unquantified at the present time”. 93 GW is studying tetrahydrocannabivarin for cbd vape liquid from india type 2 diabetes. Rick Simpson Oil Weedmaps Los Angeles 94 Epilepsy A 2012 Cochrane review said there is not enough evidence to draw conclusions about the safety or efficacy of butane hash oil extractor machine cannabinoids in the treatment of epilepsy 95 As of 2012 there have been few studies of the anticonvulsive properties of CBD and epileptic disorders. The major reasons for the lack of clinical research have been the introduction of new synthetic and more stable pharmaceutical anticonvulsants the cannabidiol hemp oil new cbd from hemp york recognition of important adverse effects and the legal restriction to the use of cannabis-derived medicines. 96 Epidiolex a cannabis-based product high cbd low thc seeds uk developed by GW Pharmaceuticals for experimental treatment of epilepsy underwent stage-two trials in the US in 2014. 97 Pairs of phase 3 trials for Dravet syndrome and Lennox-Gastaut syndrome have begun and should be completed in 2015.
These natural chemicals play a role in normal brain development and function. Marijuana overactivates parts of the brain that contain the highest number of these receptors. This causes the “high” that users feel.
However it should be noted that studies of marijuana as a “treatment” for certain mental health disorders are in preliminary phases and there is no mental health condition for which marijuana is a standard of care treatment. These findings have been replicated by myriad other studies including a new study conducted by Harvard University researchers which found that marijuana is unlikely to be the cause of illness? even in people who may be genetically predisposed to schizophrenia or other psychotic disorders. The researchers concluded “In summary we conclude that cannabis does not cause psychosis by itself.
They are also running a phase 2 study of non-psychoactive cannabidivarin 100 As of 2016 the mechanisms by which cannabis may be effective in the treatment of epilepsy remain unclear and further research is needed. 101 Glaucoma In 2009 the American Glaucoma Society noted that while cannabis can help lower intraocular pressure it recommended against its use because of “its side effects and short duration of action coupled with a lack of evidence that its use alters the course of glaucoma”. 102 As of 2008 relatively little research had been done concerning therapeutic effects of cannabinoids on the eyes. 103 Tourette syndrome A 2007 review of the history of medical cannabis said cannabinoids showed potential therapeutic value in treating Tourette syndrome (TS). 104 A 2005 review said that controlled research on treating TS with dronabinol showed the cbd oil tennessee patients taking the pill had a beneficial response without serious adverse effects; 105 a 2000 review said other studies had shown that cannabis “has no effects on tics and increases the individuals inner tension”.